Integrated ReportFiscal Year Ended Mar. 31, 2023
Our Company
-
Roundtable Discussion with the Chairperson of the Board, Executive Chairperson, and CEO
-
Initiatives for Patient Safety and Growth
-
Value Creation Model
-
Steps toward Becoming a Truly Global MedTech Company
-
Overview
-
Message from the CFO
-
Messages from Executive Officers
Our Strategy
-
Our New Company Strategy
-
ESG Strategy
-
Global Healthcare Data
-
Overview and Direction of Medical Business
-
Endoscopic Solutions Business
-
Therapeutic Solutions Business
-
Customer Voices
-
Infection Prevention
-
Innovation
-
Intellectual Property Activities
-
Medical Business Strategy: Chinese Market
-
Medical Business Strategy: Asian Emerging Markets
-
Strategic M&A
-
Care Pathway Enhancement
-
Intelligent Endoscopy Ecosystem
-
Evolving Our Corporate Culture
-
Activities to Improve Productivity
-
Carbon Neutral Society and Circular Economy
-
Responsible Supply Chain
Our Setup
-
Corporate Governance
-
Directors
-
Compliance
-
Communication with Shareholders and Investors
-
Risk Management